Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Precision BioSciences Launches IPO to Raise $126.4 Million

Durham, N.C.-based Precision BioSciences set the company’s initial public offering price at $16 per share, raising $126.4 million.

Read More »

These Seven Biotech Ideas Will Be Conversation Drivers for 2019

The online publication NEO.LIFE pointed to seven areas where biotech companies and researchers have significant potential to “dramatically reshape our concept of what it means to be human.”

Read More »

7 Biotech Trends to Look Out for in 2019

Here are seven trends most likely to be hitting the news cycle in 2019 according to BioSpace.

Read More »

Seven Trends That Shaped 2018

Barring a last-minute reversal, 2018 will likely end as a down year for the biotech industry, at least in terms of stock performance.

Read More »

Top Predictions for 2019 by Biopharma Execs

Biopharma executives were asked to predict what the next year might reveal.

Read More »

MIT Researchers Discover CRISPR Enzyme That Can Target Almost Half of Genome Locations

Researchers at the Massachusetts Institute of Technology (MIT) published research in the journal Science Advances describing yet another CRISPR improvement.

Read More »

Synthego Snags $110 Million in Series C to Advance Vision of Making CRISPR Technology More Available

Genome engineering company Synthego received an infusion of $110 million from a Series C financing round led by Peter Thiel’s Founders Fund. The funds will be used to accelerate the company’s vision to make CRISPR technology more accessible to researchers.

Read More »

FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial

The U.S. Food and Drug Administration lifted a clinical hold and accepted an Investigational New Drug Application (IND) for an experimental sickle cell disease treatment being jointly developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Read More »

Promising Early-Stage Results for Novel Malaria Therapeutics

Two antimalarial strategies have been published from Imperial College London: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.

Read More »

Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs

Researchers at the University of Texas Southwestern Medical Center used CRISPR gene editing to treat Duchenne muscular dystrophy (DMD) in dogs. Their work was published in the journal Science.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom